EUVIMED · CrossrefZeitschrift
Nature Reviews Gastroenterology & Hepatology
ISSN 1759-5045 · Springer Science and Business Media LLC
Neueste Artikel
PDE4 inhibition at the crossroads of IBD and obesity
Choosing the right drug for the right patient with steatohepatitis
Cholestasis of unknown origin in adults: more than genes
Publisher Correction: Conceptual framework and expert guidance on intrapancreatic fat deposition: the Melbourne consensus
The genomic and epigenomic evolution of colorectal cancer
Timing matters in hepatic artery thrombosis after paediatric liver transplantation
Oral IL-23 receptor blockade shows promise in ulcerative colitis
Mechanisms, management and prevention of anorectal sexually transmitted infections
Heart–liver co-management in MASLD: expert perspectives and recommendations from a multidisciplinary cardiometabolic framework
Building and regenerating intestines by manipulating intestinal stem cells
Precision nutrition for the prevention and management of inflammatory bowel disease
Global epidemiology of metabolic and alcohol-associated liver disease: risk factors, natural history and clinical implications
Cirrhosis, portal hypertension and hepatocellular carcinoma: a stage-based approach
Conceptual framework and expert guidance on intrapancreatic fat deposition: the Melbourne consensus
Microplastics, nanoplastics and liver disease: an emerging health concern?
The microbiome regulates host metabolic health and diseases through microbial enzymes
Pathophysiology of colitis-associated colorectal cancer
Metabotherapy for intestinal disease: using metabolites to prevent and treat disorders of the gut
Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management
Artificial intelligence in inflammatory bowel disease: bridging innovation, implementation and impact
Beyond class effects: moving towards drug-level precision in inflammatory bowel disease therapy
Global position statement supporting a World Health Assembly resolution on steatotic liver disease
Acute-on-chronic liver failure: pathophysiological mechanisms and clinical management
The fate of dietary protein in the gastrointestinal tract and implications for colonic disease
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of gut health
Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models
Mucosal glycans: key drivers of the development of inflammatory bowel disease and a potential new therapeutic target
WNT–β-catenin signalling in hepatocellular carcinoma: from bench to clinical trials
Mechanisms of chronic abdominal pain in inflammatory bowel disease and implications for treatment
Improving surgical treatments for hepatocellular carcinoma
EUVIMED